Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
about
Neuroprotection for treatment of glaucoma in adultsNeuroprotection for treatment of glaucoma in adultsAnti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomyNeuroprotection for treatment of glaucoma in adults.Association of IL1A and IL1B loci with primary open angle glaucoma.The immune response in glaucoma: a perspective on the roles of oxidative stressEndothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.Pharmacotherapy of glaucoma.Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB and ERK signaling pathways in BV2 cells.Functional and structural changes in a canine model of hereditary primary angle-closure glaucomaOxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.Cannabinoids and glaucomaPeroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head gliaImmune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucomaAntioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma.Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucomaRetinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).A histological analysis of the protective effect of ischemic preconditioning in the rat retina.Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions.The assessment of peripapillary retinal nerve fiber layer and macular ganglion cell layer changes in obese children: a cross-sectional study using optical coherence tomography.
P2860
Q24200657-157DDED7-BF3C-4AFD-8127-E46AF32738A1Q24240024-C7825077-B7C3-4275-BB42-24E6CD30A5EDQ28567462-F5422039-881D-466D-B022-15AC3F95617AQ30238789-0C88F494-771D-4D32-97A3-389DF4CA912BQ33611297-A8A55EF9-B0A4-4B39-9177-6D4907831F05Q34388254-262B1335-895B-4016-BA28-0446F5463E76Q34391403-68826585-84F3-4BC8-BFD8-4C2FD066094CQ35138049-C41A8CA4-D97E-4396-96E5-8CC2CC9669CFQ35223417-6C547E82-2D30-44D5-A241-C15E0F75572DQ35673897-F4FE6116-3507-4BE9-958A-7F492A639A35Q35677091-DD487C98-0D7B-4712-B310-24DF8B900058Q35748271-5D6D7A1B-7F52-4FDC-9BAC-C86CC4917372Q36370793-E0E3C792-EB9F-4A57-AAE1-C18D0F893762Q36808534-BF19E60C-EB58-4DB6-A4C6-6B696F92C082Q36811368-7A71DE11-FD01-4917-968C-9B88392C23AFQ36867011-FE9CB642-8C03-4F54-B2E3-44D7E8A38BC5Q37187224-E61605D0-BB3F-46D7-96F9-879776058891Q38963088-6355C205-5AC3-4F3A-8BA5-ADEA944BA12DQ44131523-F56AF6CC-BB37-4D61-B902-D962D3BC46CDQ45926332-23C7E9A4-24E1-4FAA-A4A6-A91A22C020FEQ48314243-1AD40775-B79B-41DB-BD06-3C7AFC6AA2EB
P2860
Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@ast
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@en
type
label
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@ast
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@en
prefLabel
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@ast
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@en
P1476
Direct and indirect approaches ...... glaucomatous optic neuropathy.
@en
P2093
P304
P356
10.1016/S0039-6257(99)00027-2
P478
43 Suppl 1
P577
1999-06-01T00:00:00Z